At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,288 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Retrospective Study on Intrapatient VAriabiLity of the Hemoglobin Levels in Anemic CKD Patients in Predialysis (Stage 3-4) and Dialysis (Stage 5) Treated With MIRCERA® (RIVAL Study)
In Brief
An observational study for Anemia. Completed, enrolled 1,288 participants across 33 sites.
Detailed Summary
This retrospective observational study will assess the incidence of hemoglobin cycling in chronic kidney disease (stage 3, 4, and 5) patients with renal anemia treated with Mircera (methoxy polyethylene glycol-epoetin beta). Data will be collected from each patient from a 9-month treatment period.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAnemia
CountriesGreece
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2010
First PostedMay 2011
Primary CompletionJul 2012
TodayJul 2026
First PostedMay 19, 2011
Enrollment StartSep 30, 2010
Primary CompletionJul 31, 2012
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 15.1 years ago